Mateusz Guzik, Robert Zymliński, Piotr Ponikowski, Jan Biegus
{"title":"急性心力衰竭患者尿氯化物的变化轨迹及其与利尿剂反应的关系。","authors":"Mateusz Guzik, Robert Zymliński, Piotr Ponikowski, Jan Biegus","doi":"10.1002/ehf2.15054","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Sodium excretion is a well-defined marker used to assess diuretic response in acute heart failure (AHF). Despite a strong pathophysiological background, the role of urine chloride excretion has not been described and established yet. We aimed to evaluate chloride trajectory during intensive diuretic treatment in AHF patients and examine its potential role in predicting poor diuretic response.</p><p><strong>Methods: </strong>The study was conducted on 50 AHF patients. Participants were included within the first 36 h of hospitalization. They received furosemide dose adjusted for body weight (half in bolus, half in 2 h infusion). Post-diuretic hourly urine collection with biochemical analysis was performed.</p><p><strong>Results: </strong>In general, the concentrations of urine chloride (uCl<sup>-</sup>) and sodium (uNa<sup>+</sup>) at the baseline samples exhibited a comparable level (71 ± 39 vs. 70 ± 44 mmol/L, respectively; P = 0.99), but across all post-furosemide study timepoints, uCl<sup>-</sup> remained significantly higher than uNa<sup>+</sup> since 1 to 6 h of the study. In this course, both ions (uCl<sup>-</sup> and uNa<sup>+</sup>) reached peak values in 2 h (114 ± 28 vs. 97 ± 34 mmol/L, respectively; P < 0.01). The pattern of uCl<sup>-</sup> dominance over uNa<sup>+</sup> concentration was also observed in separate analyses of patients naïve to furosemide and those chronically exposed to furosemide. Regardless of these patterns, naïve to furosemide individuals excreted more ions (both uCl<sup>-</sup> and uNa<sup>+</sup>) than chronically exposed patients at all timepoints. Additionally, a strong, linear correlation between uCl<sup>-</sup> and uNa<sup>+</sup> was observed in each post-furosemide timepoint (the strongest in 1 h r = 0.87; P < 0.001). Both interdependent ions concentration was almost parallel when analysed in chronic furosemide users and those naïve to furosemide separately [uCl<sup>-</sup> = 0.85 * uNa<sup>+</sup> + 28.82, P < 0.001, R<sup>2</sup> = 0.83 for chronic furosemide users, and uCl<sup>-</sup> = 0.72 * uNa<sup>+</sup> + 41.55, P < 0.001, R<sup>2</sup> = 0.65 for naïves to furosemide (linear regression model)]. Moreover, uCl<sup>-</sup> (with cutoff point: 72 mmol/L) was a satisfactory predictive factor for poor diuretic response (<100 mL/h in 6 h since the beginning of furosemide infusion) [odds ratio (OR) 95% confidence interval (CI): 39.0 (3.8-405.00)]. It presented those properties also after adjusting for urine creatinine [cutoff point: 0.296 mmol/mg-OR (95% CI): 81.0 (8.0-816.0)].</p><p><strong>Conclusions: </strong>Urine chloride and sodium are highly interrelated during decongestion of AHF patients. The uCl<sup>-</sup> (cutoff 72 mmol/L) exhibits better prognostic abilities to identify poor diuretic response than uNa<sup>+</sup>.</p>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Urine chloride trajectory and relationship with diuretic response in acute heart failure.\",\"authors\":\"Mateusz Guzik, Robert Zymliński, Piotr Ponikowski, Jan Biegus\",\"doi\":\"10.1002/ehf2.15054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Sodium excretion is a well-defined marker used to assess diuretic response in acute heart failure (AHF). Despite a strong pathophysiological background, the role of urine chloride excretion has not been described and established yet. We aimed to evaluate chloride trajectory during intensive diuretic treatment in AHF patients and examine its potential role in predicting poor diuretic response.</p><p><strong>Methods: </strong>The study was conducted on 50 AHF patients. Participants were included within the first 36 h of hospitalization. They received furosemide dose adjusted for body weight (half in bolus, half in 2 h infusion). Post-diuretic hourly urine collection with biochemical analysis was performed.</p><p><strong>Results: </strong>In general, the concentrations of urine chloride (uCl<sup>-</sup>) and sodium (uNa<sup>+</sup>) at the baseline samples exhibited a comparable level (71 ± 39 vs. 70 ± 44 mmol/L, respectively; P = 0.99), but across all post-furosemide study timepoints, uCl<sup>-</sup> remained significantly higher than uNa<sup>+</sup> since 1 to 6 h of the study. In this course, both ions (uCl<sup>-</sup> and uNa<sup>+</sup>) reached peak values in 2 h (114 ± 28 vs. 97 ± 34 mmol/L, respectively; P < 0.01). The pattern of uCl<sup>-</sup> dominance over uNa<sup>+</sup> concentration was also observed in separate analyses of patients naïve to furosemide and those chronically exposed to furosemide. Regardless of these patterns, naïve to furosemide individuals excreted more ions (both uCl<sup>-</sup> and uNa<sup>+</sup>) than chronically exposed patients at all timepoints. Additionally, a strong, linear correlation between uCl<sup>-</sup> and uNa<sup>+</sup> was observed in each post-furosemide timepoint (the strongest in 1 h r = 0.87; P < 0.001). Both interdependent ions concentration was almost parallel when analysed in chronic furosemide users and those naïve to furosemide separately [uCl<sup>-</sup> = 0.85 * uNa<sup>+</sup> + 28.82, P < 0.001, R<sup>2</sup> = 0.83 for chronic furosemide users, and uCl<sup>-</sup> = 0.72 * uNa<sup>+</sup> + 41.55, P < 0.001, R<sup>2</sup> = 0.65 for naïves to furosemide (linear regression model)]. Moreover, uCl<sup>-</sup> (with cutoff point: 72 mmol/L) was a satisfactory predictive factor for poor diuretic response (<100 mL/h in 6 h since the beginning of furosemide infusion) [odds ratio (OR) 95% confidence interval (CI): 39.0 (3.8-405.00)]. It presented those properties also after adjusting for urine creatinine [cutoff point: 0.296 mmol/mg-OR (95% CI): 81.0 (8.0-816.0)].</p><p><strong>Conclusions: </strong>Urine chloride and sodium are highly interrelated during decongestion of AHF patients. The uCl<sup>-</sup> (cutoff 72 mmol/L) exhibits better prognostic abilities to identify poor diuretic response than uNa<sup>+</sup>.</p>\",\"PeriodicalId\":11864,\"journal\":{\"name\":\"ESC Heart Failure\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESC Heart Failure\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ehf2.15054\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ehf2.15054","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Urine chloride trajectory and relationship with diuretic response in acute heart failure.
Aims: Sodium excretion is a well-defined marker used to assess diuretic response in acute heart failure (AHF). Despite a strong pathophysiological background, the role of urine chloride excretion has not been described and established yet. We aimed to evaluate chloride trajectory during intensive diuretic treatment in AHF patients and examine its potential role in predicting poor diuretic response.
Methods: The study was conducted on 50 AHF patients. Participants were included within the first 36 h of hospitalization. They received furosemide dose adjusted for body weight (half in bolus, half in 2 h infusion). Post-diuretic hourly urine collection with biochemical analysis was performed.
Results: In general, the concentrations of urine chloride (uCl-) and sodium (uNa+) at the baseline samples exhibited a comparable level (71 ± 39 vs. 70 ± 44 mmol/L, respectively; P = 0.99), but across all post-furosemide study timepoints, uCl- remained significantly higher than uNa+ since 1 to 6 h of the study. In this course, both ions (uCl- and uNa+) reached peak values in 2 h (114 ± 28 vs. 97 ± 34 mmol/L, respectively; P < 0.01). The pattern of uCl- dominance over uNa+ concentration was also observed in separate analyses of patients naïve to furosemide and those chronically exposed to furosemide. Regardless of these patterns, naïve to furosemide individuals excreted more ions (both uCl- and uNa+) than chronically exposed patients at all timepoints. Additionally, a strong, linear correlation between uCl- and uNa+ was observed in each post-furosemide timepoint (the strongest in 1 h r = 0.87; P < 0.001). Both interdependent ions concentration was almost parallel when analysed in chronic furosemide users and those naïve to furosemide separately [uCl- = 0.85 * uNa+ + 28.82, P < 0.001, R2 = 0.83 for chronic furosemide users, and uCl- = 0.72 * uNa+ + 41.55, P < 0.001, R2 = 0.65 for naïves to furosemide (linear regression model)]. Moreover, uCl- (with cutoff point: 72 mmol/L) was a satisfactory predictive factor for poor diuretic response (<100 mL/h in 6 h since the beginning of furosemide infusion) [odds ratio (OR) 95% confidence interval (CI): 39.0 (3.8-405.00)]. It presented those properties also after adjusting for urine creatinine [cutoff point: 0.296 mmol/mg-OR (95% CI): 81.0 (8.0-816.0)].
Conclusions: Urine chloride and sodium are highly interrelated during decongestion of AHF patients. The uCl- (cutoff 72 mmol/L) exhibits better prognostic abilities to identify poor diuretic response than uNa+.
期刊介绍:
ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.